Background: Vitamin D deficiency with all its consequences is a global health problem.
Background
Vitamin D deficiency is defined as 25-hydroxyvitamin D serum levels below 20 ng/ml; levels ≥20 and <30 ng/ml indicate an inadequate vitamin D status. Approximately 1 billion people worldwide have 25-hydroxyvitamin D levels below 30 ng/ml [1] . The major source of vitamin D is sunlight, which promotes subcutaneous production of vitamin D under the influence of UVB light; only 15-20% of vitamin D in the body derives from food. Apart from musculoskeletal malfunction (eg. osteomalacia, osteoporosis, muscle weakness, falls), vitamin D deficiency seems to be associated with several other diseases, e.g. cancer and cardiovascular or immunological disorders [2] . Corresponding trials demonstrated that a daily vitamin D intake of 800-1000 IU is needed to achieve and maintain 25-hydroxyvitamin D levels between 70-80 nmol/l, which are considered to be optimal for fracture prevention [3] .
Case Presentation
A 62-year-old female Caucasian was admitted to our endocrinology outpatient clinic for evaluation of osteoporosis. The patient had a history of partial gastrectomy with Billroth II reconstruction due to multiple gastric ulcers 27 years previously, and liver cirrhosis (Child A) of more than 15 years' standing due to a period of alcoholism as well as local breast cancer in 2003. For treatment of portal hypertension and recurrent ascites, she was being treated with propranolol, furosemide and spironolactone.
A fasting blood sample taken the morning after admission produced the following results , reflecting accelerated bone turnover. Standardized x-ray of the spine showed hyperkyphosis but no fractures. DXA measurement at the spine and the hip revealed osteopenia with a T-score of -1.8 SD and -2.0 SD, and osteoporosis at the distal forearm with a T-score of -2.8 SD.
The patient was advised to take an oral dose of 16 000 IU (40 drops) of vitamin D 3 per week combined with a daily supplement of 1000 mg calcium and 800 IU vitamin D 3.
At 6 weeks' follow-up, she reported that she had taken 40 drops of vitamin D 3 daily, resulting in a cumulative intake of 705 600 IU in that period. Blood analysis then showed 35 ng/ml 25-hydroxyvitamin D, with a surprisingly small increase of 15 ng/ml.
Discussion
Oral treatment with 1000 IU vitamin D daily over a period of 3-4 months raises 25-hydroxyvitamin D by about 10 ng/ml [4] . Based on this, an increase of 168 ng/ml would be expected with a daily vitamin D intake of 16 800 IU. The increase of just 15 ng/ml was a surprise. The history of Billroth II may, however, have had a negative impact on absorption, although the enteral absorption of the fat-soluble vitamin D takes place in the duodenum and the proximal jejunum, sections of the gut that are not removed as part of a Billroth II resection.
The exact mechanism of the development of vitamin D deficiency in patients following gastric surgery is not yet known. Malabsorption due to accelerated intestinal passage, impaired secretion of pancreatic enzymes and bacterial overgrowth may lead to steatorrhea [5] and so to avoidance of food rich in vitamin D, which could also contribute to vitamin D deficiency [6] .
Conclusion
Vitamin D toxicity has recently become a controversial issue. According to the literature, a vitamin D intake of 10 000 IU daily does not cause intoxication in the sense of 25-hydroxyvitamin D levels above 150 ng/ml associated with hypercalcemia and hyperphosphatemia, even in healthy people [1, 7] . Some special groups of patients may need even higher doses of supplementation to achieve satisfactory serum vitamin D levels. This case demonstrates that patients with a history of gastrointestinal surgery may need either high-dose oral vitamin D supplementation or even parenteral administration.
Consent
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Abbreviations GGT: gamma glutamyl-transferase; AST: aspartate transaminase; PTH: parathyroid hormone; DXA: dual-energy x-ray absorptiometry.
